Palo Alto Medical Foundation-Gynecologic Oncology — Mountain View, California

Public research footprint of Palo Alto Medical Foundation-Gynecologic Oncology, compiled from the ClinicalTrials.gov public registry.

129

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Recurrent Ovarian Carcinoma · Endometrial Clear Cell Adenocarcinoma · Endometrial Dedifferentiated Carcinoma · Stage IB Lung Non-Small Cell Carcinoma AJCC v7

Recently updated registry entries

NCT03712605 — Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After… (Active Not Recruiting)
NCT00977574 — Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or… (Active Not Recruiting)
NCT02224781 — Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Palo Alto Medical Foundation-Gynecologic Oncology?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.